208 related articles for article (PubMed ID: 38393490)
41. Exosomes from senescent epithelial cells activate pulmonary fibroblasts via the miR-217-5p/Sirt1 axis in paraquat-induced pulmonary fibrosis.
Zhang M; Xue X; Lou Z; Lin Y; Li Q; Huang C
J Transl Med; 2024 Mar; 22(1):310. PubMed ID: 38532482
[TBL] [Abstract][Full Text] [Related]
42. Aging aggravates alcoholic liver injury and fibrosis in mice by downregulating sirtuin 1 expression.
Ramirez T; Li YM; Yin S; Xu MJ; Feng D; Zhou Z; Zang M; Mukhopadhyay P; Varga ZV; Pacher P; Gao B; Wang H
J Hepatol; 2017 Mar; 66(3):601-609. PubMed ID: 27871879
[TBL] [Abstract][Full Text] [Related]
43. [Updated roles of SIRT1 in prostate diseases].
Ma ZM; Tian YJ; Wang ZP; Zhai ZX
Zhonghua Nan Ke Xue; 2016 Apr; 22(4):356-60. PubMed ID: 30088710
[TBL] [Abstract][Full Text] [Related]
44. Amifostine ameliorates bleomycin-induced murine pulmonary fibrosis via NAD
Guo F; Xu F; Li S; Zhang Y; Lv D; Zheng L; Gan Y; Zhou M; Zhao K; Xu S; Wu B; Deng Z; Fu P
Eur J Med Res; 2024 Jan; 29(1):68. PubMed ID: 38245795
[TBL] [Abstract][Full Text] [Related]
45. Sirtuin1 Protects against Systemic Sclerosis-related Pulmonary Fibrosis by Decreasing Proinflammatory and Profibrotic Processes.
Chu H; Jiang S; Liu Q; Ma Y; Zhu X; Liang M; Shi X; Ding W; Zhou X; Zou H; Qian F; Shaul PW; Jin L; Wang J
Am J Respir Cell Mol Biol; 2018 Jan; 58(1):28-39. PubMed ID: 28800254
[TBL] [Abstract][Full Text] [Related]
46. Lysophosphatidic Acid Promotes Epithelial to Mesenchymal Transition in Ovarian Cancer Cells by Repressing SIRT1.
Ray U; Roy SS; Chowdhury SR
Cell Physiol Biochem; 2017; 41(2):795-805. PubMed ID: 28214851
[TBL] [Abstract][Full Text] [Related]
47. Jiedu Tongluo Baoshen formula enhances renal tubular epithelial cell autophagy to prevent renal fibrosis by activating SIRT1/LKB1/AMPK pathway.
Jin D; Zhao Y; Sun Y; Xue J; Li X; Wang X
Biomed Pharmacother; 2023 Apr; 160():114340. PubMed ID: 36738503
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of lung protection of Sanghuangporus sanghuang through TLR4/NF-κB/MAPK, keap1/Nrf2/HO-1, CaMKK/AMPK/Sirt1, and TGF-β/SMAD3 signaling pathways mediating apoptosis and autophagy.
Chien LH; Deng JS; Jiang WP; Chou YN; Lin JG; Huang GJ
Biomed Pharmacother; 2023 Sep; 165():115080. PubMed ID: 37392658
[TBL] [Abstract][Full Text] [Related]
49. SIRT1 promotes epithelial-mesenchymal transition and metastasis in colorectal cancer by regulating Fra-1 expression.
Cheng F; Su L; Yao C; Liu L; Shen J; Liu C; Chen X; Luo Y; Jiang L; Shan J; Chen J; Zhu W; Shao J; Qian C
Cancer Lett; 2016 Jun; 375(2):274-283. PubMed ID: 26975631
[TBL] [Abstract][Full Text] [Related]
50. Epidermal SIRT1 regulates inflammation, cell migration, and wound healing.
Qiang L; Sample A; Liu H; Wu X; He YY
Sci Rep; 2017 Oct; 7(1):14110. PubMed ID: 29074993
[TBL] [Abstract][Full Text] [Related]
51. Integrated long non-coding RNA analyses identify novel regulators of epithelial-mesenchymal transition in the mouse model of pulmonary fibrosis.
Sun H; Chen J; Qian W; Kang J; Wang J; Jiang L; Qiao L; Chen W; Zhang J
J Cell Mol Med; 2016 Jul; 20(7):1234-46. PubMed ID: 26824344
[TBL] [Abstract][Full Text] [Related]
52. Emerging therapeutic strategy for mitigating cancer progression through inhibition of sirtuin-1 and epithelial-mesenchymal transition.
El-Ashmawy NE; Khedr EG; Khedr NF; El-Adawy SA
Pathol Res Pract; 2023 Nov; 251():154907. PubMed ID: 37925819
[TBL] [Abstract][Full Text] [Related]
53. Apigenin Alleviates Oxidative Stress-Induced Cellular Senescence via Modulation of the SIRT1-NAD[Formula: see text]-CD38 Axis.
Li BS; Zhu RZ; Lim SH; Seo JH; Choi BM
Am J Chin Med; 2021; 49(5):1235-1250. PubMed ID: 34049472
[TBL] [Abstract][Full Text] [Related]
54. PIASy mediates hypoxia-induced SIRT1 transcriptional repression and epithelial-to-mesenchymal transition in ovarian cancer cells.
Sun L; Li H; Chen J; Iwasaki Y; Kubota T; Matsuoka M; Shen A; Chen Q; Xu Y
J Cell Sci; 2013 Sep; 126(Pt 17):3939-47. PubMed ID: 23843607
[TBL] [Abstract][Full Text] [Related]
55. Nrf2 antioxidant pathway suppresses Numb-mediated epithelial-mesenchymal transition during pulmonary fibrosis.
Zhang Z; Qu J; Zheng C; Zhang P; Zhou W; Cui W; Mo X; Li L; Xu L; Gao J
Cell Death Dis; 2018 Jan; 9(2):83. PubMed ID: 29362432
[TBL] [Abstract][Full Text] [Related]
56. PARP1 inhibitor (PJ34) improves the function of aging-induced endothelial progenitor cells by preserving intracellular NAD
Zha S; Li Z; Cao Q; Wang F; Liu F
Stem Cell Res Ther; 2018 Aug; 9(1):224. PubMed ID: 30139380
[TBL] [Abstract][Full Text] [Related]
57. Sirt 1 activator attenuates the bleomycin-induced lung fibrosis in mice via inhibiting epithelial-to-mesenchymal transition (EMT).
Rong L; Wu J; Wang W; Zhao RP; Xu XW; Hu D
Eur Rev Med Pharmacol Sci; 2016 May; 20(10):2144-50. PubMed ID: 27249616
[TBL] [Abstract][Full Text] [Related]
58. SIRT1: An Intermediator of Key Pathways Regulating Pulmonary Diseases.
Jiang YZ; Huang XR; Chang J; Zhou Y; Huang XT
Lab Invest; 2024 May; 104(5):102044. PubMed ID: 38452903
[TBL] [Abstract][Full Text] [Related]
59. Targeting Sirtuin1 to treat aging-related tissue fibrosis: From prevention to therapy.
Han X; Ding C; Sang X; Peng M; Yang Q; Ning Y; Lv Q; Shan Q; Hao M; Wang K; Wu X; Zhang H; Cao G
Pharmacol Ther; 2022 Jan; 229():107983. PubMed ID: 34480962
[TBL] [Abstract][Full Text] [Related]
60. Chinese medicine as a therapeutic option for pulmonary fibrosis: Clinical efficacies and underlying mechanisms.
Hao Y; Li J; Dan L; Wu X; Xiao X; Yang H; Zhou R; Li B; Wang F; Du Q
J Ethnopharmacol; 2024 Jan; 318(Pt A):116836. PubMed ID: 37406748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
